Can't find what you're looking for? Email us about the title you want and we'll do our best to help.
Department of Health Thesaurus of Health and Social Care Terms.
3rd edition.
The DH-Data Thesaurus.
Department of
Health. April 2002.
A
two-volume thesaurus of key terms covering the core areas of health and social
welfare and the subjects of health services, health administration and
equipment, human biology, preventive and clinical medicine, drugs and the safety
of medicines, medical supplies, pathology, nursing practice and administration,
social services and social work. This edition is markedly
different from the previous editions (the last published in 1993) in a number of
respects: The structure of the thesaurus has been completely overhauled and
revised The entire Health Management Information Consortium (HMIC)
thesaurus has been absorbed within this thesaurus Over 2000
new terms have been added and about 400 terms have been deleted Following the division of the Department of Health and Social
Security into separate departments many of the social security terms have been
removed Two new forms of term, Specifiers and Indicators, have been
introduced Brackets have been removed from many terms The introduction has been rewritten. A comprehensive thesaurus of key terms in health and social
welfare.
ISBN 0113225601 $162.00
Design
and Implementation of Health Information Systems.
WHO.
2001.
This book provides a practical guide to the design and
implementation of health information systems in developing countries. Noting
that most existing systems fail to deliver timely, reliable, and relevant
information, the book responds to the urgent need to restructure systems and
make them work as both a resource for routine decisions and a powerful tool for
improving health services. With this need in mind, the authors draw on their
extensive personal experiences to map out strategies, pinpoint common pitfalls,
and guide readers through a host of conceptual and technical options.
Information needs at all levels - from patient care to management of the
national health system - are considered in this comprehensive guide. Details
range from a list of weaknesses that plague most existing systems, through
advice on when to introduce computers and how to choose appropriate software and
hardware, to the hotly debated question of whether patient records should be
kept by the patient or filed at the health unit. Case studies and numerous practical examples are used to
explore problems and illustrate solutions. The book also provides a step-by-step guide to the
restructuring of information systems aimed at improving the quality and
relevance of data and ensuring their better use in planning and management.
Paperback, xi + 270 pp.
ISBN 9241561998 $88.00
The Directory of On-Going Cancer
Research in the European Union, 2002-2003.
Edited by Christine Mauwet. Feb
2002.
This is the first edition of the
directory which presents information on 1,800 cancer research programs in
progress throughout the EU. Its aim is to enable researchers to find out about
other European research projects and possible collaboration opportunities. The
directory covers the programs being conducted by the European Organization for
Research and Treatment of Cancer (EORTC) and the range of programs by research
organizations in each of the 15 EU member states, as well as research programs
in the USA, Canada and Switzerland. The information contained in the Directory
has been compiled on the basis of a questionnaire sent to each research
establishment.
ISBN 2930066520 $180.00
Drug Facts and Comparisons.
Facts & Comparisons. 2001.
This is the pocket version of Drugs Fact
and Comparisons (DFC), a loose-leaf drug information service published in the
USA. This version is designed to provide an easy-to-use, concise, portable tool
for daily practice at the point of care. Aimed at professionals, it gives
information on over 600 generic drugs, with 2000+ representative trade names. It
is organized in twelve therapeutic categories to enable identification and
comparison of similar agents. The categories are nutritionals, blood modifiers,
hormones, cardiovasculars, respiratories, CNS drugs, gastrointestinals, anti-infectives,
biologicals, topicals, antieoplastics, and miscellaneous. Product tables which
list trade names, methods of dosage, strengths and manufacturers are given at
the beginning of each drug description. Actions, indications, contraindications,
warnings, drug interactions and significant adverse reactions are also included.
Paperback, x + 1020 pp.
ISBN 1574390554
$74.00
Drug Use in Prison.
Richard
Muscat. 2001.
Because of the nature of
prisons, it is generally assumed that drug use does not occur. However,
epidemiological data from around Europe including prevalence studies shows us
this is in fact not the case. There is ample evidence to suggest that drug use
is common. This publication describes the current situation with regards to drug
use in prison and focuses on the following countries: Estonia, Greece, France,
Ireland, Malta, the Netherlands, Portugal, the Russian Federation, Spain, the
Slovak Republic and the United Kingdom. Paperback, 156 pp.
ISBN 9287145210 $20.00
Dying to Win.
2nd edition.
Doping in Sport and the Development of Anti-Doping Policy.
Barrie Houlihan. June
2002.
Doping in the sports world is taking on
dramatic proportions. It may make the difference which could win an athlete a
gold medal, lucrative sponsorship and global adulation. But doping undermines
the integrity of sport and is a real danger to the health of thousands of
athletes. What sports rely on what drugs to sustain performance or to build up
the appropriate muscles? How do certain drugs affect the athlete's body? How are
such drugs monitored and what masking agents are applied to hide their use?
These questions and more are answered in this fully revised edition. New
developments in genetic engineering and gene therapy are also discussed. One of
the main messages in his book is that the control of doping requires a
re-evaluation of the direction of future anti-doping policy, particularly in the
light of the recent establishment of the World Anti-Doping Agency. The book
features a list of useful internet resources, as well as a list of prohibited
pharmacological classes of doping agents and doping methods. Paperback, 240 pp.
ISBN 9287146853 $36.00
Efficacy and Radiation
Safety in Interventional Radiology.
A Focus for Health Education.
World Health
Organisation (WHO). 2001.
Interventional radiology procedures are
becoming ever more important in the effective diagnosis of both cardiovascular
and non-vascular diseases. Their use facilitates - and often replaces - surgery,
thus reducing hospitalization time; in fact, many interventions can now be
undertaken on an outpatient basis. However, interventional radiology typically
involves more prolonged exposure to radiation than conventional X-ray
examination, and the benefits of the procedure must therefore be carefully
weighed against safety considerations, both for patients and for clinical staff.
This publication reflects continuing efforts by WHO to improve the quality and
safety of radiological services. It describes the principal interventional
procedures and their application, and examines the associated risks. It gives
measures for reducing exposure of patients and staff are emphasized throughout
and the importance of adequate and continuing training of medical staff of all
levels is stressed. It offers guidance on equipment specifications underlining
again the need to achieve a rational balance between clinical efficacy and
reduction of radiation exposure. This book holds valuable information, whether
purchasing new equipment for a single medical facility, or establishing an
interventional radiology service at the national level. This book's target
market is clinicians and public health administrators.
Paperback.
ISBN 9241545291 $39.00
Encyclopaedia of
Occupational Health and Safety. 4th edition.
Edited by Jeanne
Mager Stellman. 1998.
Contents: Vol.1 The body health care
management & policy tools & approaches. Vol. 2 Hazards. Vol. 3
Industries & occupations. Vol.4 Guides, indexes, directory. Hardcover, 4
volumes, 4000+
pp., includes 1000 illustrations..
ISBN 9221092038 $535.00
Ethical
Eye - Cloning.
Council of Europe. April 2002.
In
this publication, scientists, philosophers, lawyers
and journalists explain the ethical issues linked with
various cloning techniques and put forward their
differing view on the matter. Some of the questions
answered include: does therapeutic cloning pave the
way to the cloning of human beings? And should we
allow ourselves to be guided by the possibilities
thrown up by technology or should we first define the
world in which we want to live?
Key features:
Provides
information on some of the basic scientific concepts Illustrations and website referenced given,
making the publication easy to read and understand
Contributions on different subjects made by many
different professors and experts.
ISBN
9287147027 $20.00
Ethical Eye: Euthanasia.
Council of Europe. July
2003.
In producing this series, the Council of
Europe, the longest-standing human rights organization in Europe, provides a
unique insight into the ethical concerns related to recent scientific
developments. It does so by presenting the opinions of a wealth of
international experts from such diverse fields as legal, scientific,
academic, religious and others. Paperback.
ISBN 9287150702
$20.00
BACK TO TOP
Eudralex.
The Rules Governing Medicinal Products in the European Union.
European Communities
Commission. Directorate-General for Industry, Pharmaceuticals and Cosmetics.
All volumes are paperbacks published
between 1998 and 1999. Volumes sold individually -- please email us with
inquiries about buying a full set.
Vol. 1: Pharmaceutical
legislation: medicinal products for human use.
ISBN 9282820327 $65.00
Vol. 2: Notice to applicants: medicinal products for
human use. ISBN 011975780X $95.00
Vol. 3: Guidelines: medicinal products for human use.
ISBN 9282824365 $175.00
Vol. 4: Good manufacturing practices: medicinal products
for human and veterinary use. ISBN 9282820297
$36.00
Vol. 5: Pharmaceutical legislation: veterinary medicinal
products. ISBN 9282820378 $57.00
Vol. 6: Notice to applicants: veterinary medical
products. ISBN 0119853515 $80.00
Vol. 7. Guidelines: Veterinary medicinal products.
ISBN 0119853663 $115.00
The
European Health Report 2002.
WHO. Oct 2002.
This
report responds to the statutory requirement to provide the Member States with
essential public health information. It provides a broad but concise picture of
the health status and health determinants in the Region, and identifies areas
for public health action for the Member States and the public health community.
The report focuses on concrete evidence useful for decision-makers in public
health. Its role is to summarize and feed back to the Member States the
information created, deposited and 'accredited' during the Regional Office's
work with Member States on key topics and issues in public health in Europe.
Paperback, 156 pp.
ISBN
9289013656 $54.00
European Pharmacopoeia, 5th ed, comes into force
on the 1st of January 2005 and will consist of a 2-volume main edition. It will
be updated on a regular basis (3 per year) by a collection of 8 non-cumulative
supplements.
Key features:
$860.00 for the printed main edition and 1st 2 supplements. ISBN: 011989288X. CDROM version $750.00, version 5.1 & 5.2,
Supplement 5.3. ISBN 9287156417. $144.00
Supplement 5.4. ISBN 9287156433. $144.00
Supplement 5.5 ISBN 9287156468. $144.00
Supplement 5.6. ISBN 9287158363. $144.00 due end of June
5.7 to 5.8 to be published 2006-2007
European Pharmacopoeia CD Rom Single User (Covers Supplements 3, 4 and 5)- For existing subscribers. ISBN 9287156484. $450.00
European Pharmacopoeia CD Rom Single User (Covers Supplements 3, 4 and 5) - For new subscribers. ISBN 9287156514. $1400.00
Evaluation in Health Promotion.
Principles and Perspectives.
WHO. 2001.
Policy-makers, professionals of all kinds and the general public increasingly
recognize social and economic factors as important determinants of health.
Because health promotion approaches address these factors, they can play an
increasingly valuable role in protecting and improving health. At the same time,
funding sources increasingly demand evidence that initiatives give value for
money. Health promotion initiatives need effective evaluation to realise their
potential: both to prove their value as investments and to increase their
effectiveness in achieving their aims. To help meet this need, the WHO European
Working Group on Health Promotion Evaluation examined the current range of
qualitative and quantitative evaluation methods to provide guidance to
policy-makers and practitioners. This book is the result. It comprises an
extensive compilation and discussion of the theory, methodologies and practice
of evaluating health promotion initiatives in Europe and the Americas. The book
takes three perspectives in examining the issues. It includes a retrospective
examination of the evolution of health promotion evaluation. This provides the
context for assessing and understanding the current state of evaluations of
initiatives addressing settings, polices and systems works for promoting health.
Finally the chapter authors and the Working Group as a whole make many
recommendations for improvement that provide a look into the future. This book
shows how a health promotion approach offers a comprehensive framework for
planning and implementing interventions that can effectively address today's
major health-related problems. The authors describe how good evaluations assist
initiatives in achieving their goals, provide a wealth of guidance on how to
undertake them and call for greater investment in the evaluation of health
promotion.
ISBN 9289013591 $135.00
Foodborne Disease.
General Guidelines
for Methodologies on Research and Evaluation of Traditional Medicine.
WHO. 2002.
These general guidelines have been developed to
consider the types of academic research methods used to evaluate the safety and
efficacy of traditional medicine. They aim to harmonize the use of certain
accepted and important terms, and provide appropriate evaluation methods to aid
the development of regulation and registration mechanisms. The guidelines
contain sections on: herbal medicines, traditional procedure-based therapies,
clinical research, and related issues including ethics, education and training,
and surveillance systems. Paperback. vi + 71 pp.
ISBN 0119869357 $24.00
Genetic Testing.
Policy Issues for the New
Millennium.
Science and Innovation Series.
OECD. 2001.
Genetic tests are being developed at an impressive rate and a significant number
have already reached the market. Substantial involvement of the private sector
has led to unprecedented growth in commercial genetic testing services and in
trade of such services. This trend is expected to increase as knowledge gained
from the mapping of the human genome and of single nucleotide polymorphisms (SNPs)
is applied to the identification of disease-causing genes and of inherited
differences in drug response. The potential socio-economic and ethical impacts
are staggering. This report provides a state-of-the-art review of advances in
genetic testing and of main international policy concerns drawing from the OECD
workshop on Genetic Testing: Policy Issues for the New Millennium held in
Vienna on 23-25 February 2000. Paperback, 76 pp.
ISBN 9264183043 $24.00
Genomics
and World Health.
Report of the Advisory Committee on
Health Research.
WHO Advisory
Committee on Health Research. May 2002.
Intended to highlight the relevance of
genomics (the study of genomes) for health care world wide, this new report from
the WHO addresses the many issues around the use of human genomes and the
control of diseases using gene therapy. Key Features: Addresses the potential
risks and hazards of the applications of genomics and their control Examines
the ethical issues connected with genetic research Specific focus given to the
potential of genomics for improving health care in developing countries.
Paperback, 241 pp.
ISBN
9241545542 $64.00
Global Illicit Drug Trends
2000.
United Nations Office for
Drug Control & Crime Prevention. 2000.
The United Nations has set an objective
to make significant progress towards the control and supply of illicit drugs by
the year 2008. This objective can only be achieved by giving demand as much
attention as supply and on the basis of regular assessments of the drug problem.
This report aims to contribute to such assessments by presenting supply and
demand statistics and analysis on the evolution of the global illicit drug
problem. It is based on data obtained primarily from the annual reports
questionnaire (ARQ) sent by governments to the United Nations Drug Control
Programme (UNDCP) in 1999, supplemented by other sources when necessary and when
available. The UNDCP finds these data sources limited in that the ARQ reporting
is not systematic enough, both in terms of numbers of countries responding and
of content, and, most countries lack adequate monitoring systems to produce
reliable, comprehensive and internationally comparable data. The report includes
an analysis of the current situation and tables of estimates covering
production, trafficking and consumption. Paperback, 219 pp.
ISBN 9211481309 $44.00
Guide to the
Preparation, Use and Quality Assurance of Blood Components.
9th Edition.
Council of Europe. 2002.
In the absence of substitutes, the use of blood components remains essential in
therapy. This new edition presents a compendium of measures designed to ensure
the safety, efficacy and quality of blood components and is particularly
intended for all those working in blood transfusion services. In accordance with
the approach recommended by the Council of Europe, the guide is based on the
premise of voluntary, non-remunerated blood donation. It also describes the
different blood components and gives information on their clinical indications
and possible side effects. Adopted in 1995 as a technical appendix to
Recommendation no. R (95) 15 of the Council of Europe, this guide continues to
be the 'Golden Standard' for blood transfusion services and forms the basis for
many national guidelines, in Europe and outside. For example, in 2000 Australia
mandated the guide in its standard for blood components. In this 8th edition,
chapter 12 on red cells obtained by aphaeresis has been completely overhauled.
Where necessary, chapters have been revised in order to take into account what
can be achieved with new technology. For example, in chapter 1 on selection of
donors the requirements for aphaeresis donors have been updated. The Guide to
the Preparation, Use and Quality Assurance of Blood Components will be of
interest to blood transfusion centers, legislators, health personnel and all
those working in the field of blood transfusion. Paperback, 267 pp.
ISBN 9287150753 $34.00
Guidelines for Evaluation of Environmental
Health Services.
European Series No. 90.
WHO. 2001.
Evaluation of health services is an established field. Several books and reports have been published on the subject, both inside and outside of WHO. This publication does not intend to rewrite these documents or restate their arguments. Its goal is to introduce environmental health professionals to evaluate principles, tools and examples from which they can pick and choose elements to suit their needs. The
book is designed to guide practitioners towards questions that must be answered to evaluate and improve services,
and it also provides references and suggestions for further reading. Paperback, 185pp.
ISBN 9289013575 $56.00
The Government's Response to the Children's Safeguards Review.
Command Paper.
4105.
Department of Health. 1998.
Paperback, 104 pp.
ISBN 0101410522 $30.00
Prices may fluctuate with the Currency Exchange Rate
Back to Home | Company Info | Ordering | Shipping & Tracking | Publishers | Meetings | Search | Site Index | Feedback